US 11337971
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof
granted A61KA61K31/485A61K31/496
Quick answer
US patent 11337971 (Dopamine D3 receptor selective antagonists/partial agonists and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/485, A61K31/496, A61P, A61P25/36